<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2936</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2020.121910</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Nanotechnology: A Curative Approach to Combat HIV-AIDS&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Baghel</surname><given-names>Manoj</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sailaja</surname><given-names>Inampudi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shaker</surname><given-names>Ivvala Anand</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>6</day><month>10</month><year>2020</year></pub-date><volume>9)</volume><issue/><fpage>149</fpage><lpage>161</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>HIV-AIDS is one of the biggest challenges of the 21st century to cure. However, in the current scenario, various antiretroviral drugs are available which makes the condition chronic rather than worse which manages to increase the survival rate. Antiretroviral drugs are manageable but the bioavailability, lower permeability; poor half-life of the drug limits the potent activity. High dose drug administration leads to higher toxicity which arrays adverse effects and develops resistance against HIV strain. Potent targeting of drugs is lacking due to its instability, chemical degradation, and tissue barrier restriction. The application of nanotechnology to anti-retroviral drug delivery holds the capacity to cure AIDS. The nanotechnology-based efficient delivery system of Nanocarrier (liposomes, dendrimers, nanoparticles, polymeric micelles, nano-emulsion, nanovesicles) plays a major role in drug delivery. Nanocarrier has revolutionized the field of pharmaceutics in the world of drug delivery. This review depicts the nano-based system which is incorporated or encased with ARV drug to increase its efficiency or effectiveness with low adverse effect to abort HIV.&#13;
</p></abstract><kwd-group><kwd> Antiretroviral drug</kwd><kwd> Nanocarrier</kwd><kwd> HIV</kwd><kwd> AIDS</kwd><kwd> Nanotechnology</kwd><kwd> Drug delivery</kwd></kwd-group></article-meta></front></article>
